Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01669252
Brief Title: Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer (NeoEribulin)

First Submitted : August 9, 2012
First Submitted that Met QC Criteria : August 16, 2012
First Posted : August 20, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : October 31, 2017
Last Update Posted : November 6, 2017